Curiox Biosystems Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-23,247	-8,089	-10,040	-11,495	-14,524	-6,279
Depreciation & Amortization	2,670	2,578	1,952	1,598	1,236	1,120
Loss (Gain) From Sale of Assets	115.44	123.27	-13.02	12.11	-	-
Asset Writedown & Restructuring Costs	479.78	-	-	-	84.1	-
Stock-Based Compensation	870.39	777.17	-8.84	678.35	613.76	167.82
Provision & Write-off of Bad Debts	6.65	2.14	17.29	1.88	12.66	27.41
Other Operating Activities	10,063	-5,163	-334.89	301.64	7,214	3,307
Change in Accounts Receivable	452.99	2,737	227.68	1,212	75.22	-2,227
Change in Inventory	-1,043	-458.81	195.89	-829.5	-1,163	137.56
Change in Accounts Payable	-622.91	-1,196	-688.69	-1,509	809.8	1,192
Change in Other Net Operating Assets	144.19	-1,009	528.91	140.75	516.07	-106.52
Operating Cash Flow	-10,111	-9,698	-8,164	-9,888	-5,126	-2,661
Capital Expenditures	-255.49	-257.88	-211.53	-822.86	-261.26	-188.39
Sale of Property, Plant & Equipment	-	-	1.79	-	-	58.68
Sale (Purchase) of Intangibles	-	-	-	-17.9	-	-
Investment in Securities	-3,000	-4,000	3,125	5,691	-8,007	2,260
Other Investing Activities	25.61	-16.81	-16.69	-116.92	-43.25	-26.19
Investing Cash Flow	-3,230	-4,275	2,898	4,734	-8,311	2,105
Long-Term Debt Issued	-	19,998	-	-	-	131.79
Long-Term Debt Repaid	-	-397.16	-320.22	-236.66	-93.69	-34.29
Net Debt Issued (Repaid)	-424.94	19,600	-320.22	-236.66	-93.69	97.51
Issuance of Common Stock	788.02	260.9	17,964	-	-	-
Other Financing Activities	27.68	-0	-0	-	13,087	-
Financing Cash Flow	390.76	19,861	17,644	-236.66	16,999	97.51
Foreign Exchange Rate Adjustments	619.03	390.05	-65.54	-15.47	397.85	-185.72
Net Cash Flow	-12,331	6,279	12,312	-5,407	3,960	-644.51
Free Cash Flow	-10,366	-9,956	-8,376	-10,711	-5,387	-2,849
Free Cash Flow Margin	-243.44%	-217.02%	-123.39%	-148.00%	-97.54%	-64.99%
Free Cash Flow Per Share	-637.41	-604.30	-585.95	-1509.32	-413.36	-218.63
Cash Interest Paid	26	34.68	25.7	29.23	9.35	3.2
Cash Income Tax Paid	27.4	50.11	11.81	16.14	-3.84	8.8
Levered Free Cash Flow	-17,793	3,490	-3,723	-8,886	-4,602	-
Unlevered Free Cash Flow	-16,862	3,929	-3,707	-7,150	-3,537	-
Change in Working Capital	-1,068	72.97	263.79	-985.77	238.26	-1,004

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.